Client News

Mallia to Showcase Innovative sCD83-Based Approach for Hair Growth at HairS‘25 Symposium

Formycon Bond 2025/2029: Public Subscription now also Possible via Deutsche Börse

Formycon AG: Subscription Period for 2025/2029 Corporate Bond has Started

Formycon Plans Public Corporate Bond Issuance to Support Next Growth Phase within Attractive Biosimilar Markets

AFYREN Begins New Phase of Industrial Strategy as First Plant AFYREN NEOXY Achieves Continuous Production

MIG Capital Announces €50 Million in Series A Funding for Look Up

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Mallia Secures European Patent Covering sCD83 for Hair Growth and Wound Healing

PL BioScience Strengthens Management Team with Appointment of Oliver Dick as Chief Technology Officer